Symbol="EVOK"
AssetType="Common Stock"
Name="Evoke Pharma Inc"
Description="Evoke Pharma, Inc., a specialty pharmaceutical company, focuses primarily on the development and commercialization of drugs for the treatment of gastroenterological diseases and disorders. The company is headquartered in Solana Beach, California."
CIK="1403708"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="420 STEVENS AVENUE, SUITE 370, SOLANA BEACH, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="3677400"
EBITDA="None"
PERatio="None"
PEGRatio="-0.1"
BookValue="0.161"
DividendPerShare="0"
DividendYield="0"
EPS="-2.33"
RevenuePerShareTTM="1.068"
ProfitMargin="-2.221"
OperatingMarginTTM="-2.118"
ReturnOnAssetsTTM="-0.404"
ReturnOnEquityTTM="-2.051"
RevenueTTM="3570200"
GrossProfitTTM="2138300"
DilutedEPSTTM="-2.33"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="1.45"
AnalystTargetPrice="7"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="3.048"
PriceToBookRatio="1.033"
EVToRevenue="0.0648"
EVToEBITDA="0.195"
Beta="0.332"
num_52WeekHigh="5.96"
num_52WeekLow="1.05"
num_50DayMovingAverage="1.538"
num_200DayMovingAverage="2.212"
SharesOutstanding="3343100"
DividendDate="None"
ExDividendDate="None"
symbol="EVOK"
open="1.06"
high="1.15"
low="1.05"
price="1.08"
volume="8279.00"
latest_trading_day="2023-08-25"
previous_close="1.10"
change="-0.02"
change_percent="-1.8182%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="100"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="0"
Volume_recent_avg="23712"
Change_recent_avg="-0.02"
Delta_recent_avg="0.13"
Variance_recent_avg="0.06"
Change_ratio_recent_avg="-0.96"
RSI_change="FALSE"
ADX_change="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="0"
Aroon_momentum_negative="100"
image_negative_thumbnail_id_1="95"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0081.jpeg"
image_negative_thumbnail_id_2="136"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0040.jpeg"
image_neutral_thumbnail_id_1="553"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0046.jpeg"
image_neutral_thumbnail_id_2="546"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0053.jpeg"
image_positive_thumbnail_id_1="620"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0088.jpeg"
image_positive_thumbnail_id_2="978"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0140.jpeg"
image_professor_thumbnail_id_1="1202"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0036.jpeg"
image_professor_thumbnail_id_2="1186"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
